BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mohammad H, AbdelKhalek A, Abutaleb NS, Seleem MN. Repurposing niclosamide for intestinal decolonization of vancomycin-resistant enterococci. Int J Antimicrob Agents 2018;51:897-904. [PMID: 29432868 DOI: 10.1016/j.ijantimicag.2018.02.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang W, Ran J, Shang L, Zhang L, Wang M, Fei C, Chen C, Gu F, Liu Y. Niclosamide as a repurposing drug against Gram-positive bacterial infections. J Antimicrob Chemother 2022:dkac319. [PMID: 36173387 DOI: 10.1093/jac/dkac319] [Reference Citation Analysis]
2 Gargvanshi S, Gutheil WG. Library Screening for Synergistic Combinations of FDA-Approved Drugs and Metabolites with Vancomycin against VanA-Type Vancomycin-Resistant Enterococcus faecium. Microbiol Spectr 2022;:e0141222. [PMID: 35969069 DOI: 10.1128/spectrum.01412-22] [Reference Citation Analysis]
3 Vazquez-Rodriguez JA, Shaqour B, Guarch-Pérez C, Choińska E, Riool M, Verleije B, Beyers K, Costantini VJA, Święszkowski W, Zaat SAJ, Cos P, Felici A, Ferrari L. A Niclosamide-releasing hot-melt extruded catheter prevents Staphylococcus aureus experimental biomaterial-associated infection. Sci Rep 2022;12:12329. [PMID: 35854044 DOI: 10.1038/s41598-022-16107-4] [Reference Citation Analysis]
4 Lu T, Zheng X, Mao F, Cao Q, Cao Q, Zhu J, Li X, Lan L, Li B, Li J. Novel niclosamide-derived adjuvants elevating the efficacy of polymyxin B against MDR Pseudomonas aeruginosa DK2. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114318] [Reference Citation Analysis]
5 Peyclit L, Baron SA, Hadjadj L, Rolain J. In Vitro Screening of a 1280 FDA-Approved Drugs Library against Multidrug-Resistant and Extensively Drug-Resistant Bacteria. Antibiotics 2022;11:291. [DOI: 10.3390/antibiotics11030291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Abutaleb NS, Elhassanny AE, Seleem MN. In vivo efficacy of acetazolamide in a mouse model of Neisseria gonorrhoeae infection. Microbial Pathogenesis 2022. [DOI: 10.1016/j.micpath.2022.105454] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Gontijo AVL, Pereira SL, de Lacerda Bonfante H. Can Drug Repurposing be Effective Against Carbapenem-Resistant Acinetobacter baumannii? Curr Microbiol 2021;79:13. [PMID: 34905109 DOI: 10.1007/s00284-021-02693-5] [Reference Citation Analysis]
8 Lal J, Kaul G, Akhir A, Ansari SB, Chopra S, Reddy DN. Bio-evaluation of fluoro and trifluoromethyl-substituted salicylanilides against multidrug-resistant S. aureus. Med Chem Res 2021;:1-15. [PMID: 34720564 DOI: 10.1007/s00044-021-02808-4] [Reference Citation Analysis]
9 Abutaleb NS, Elhassanny AEM, Flaherty DP, Seleem MN. In vitro and in vivo activities of the carbonic anhydrase inhibitor, dorzolamide, against vancomycin-resistant enterococci. PeerJ 2021;9:e11059. [PMID: 33850651 DOI: 10.7717/peerj.11059] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
10 Abutaleb NS, Seleem MN. In vivo efficacy of auranofin in a hamster model of Clostridioides difficile infection. Sci Rep 2021;11:7093. [PMID: 33782498 DOI: 10.1038/s41598-021-86595-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Abutaleb NS, Elkashif A, Flaherty DP, Seleem MN. In Vivo Antibacterial Activity of Acetazolamide. Antimicrob Agents Chemother 2021;65:e01715-20. [PMID: 33495225 DOI: 10.1128/AAC.01715-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
12 AbdelKhalek A, Seleem MN. Repurposing the Veterinary Antiprotozoal Drug Ronidazole for the Treatment of Clostridioides difficile Infection. Int J Antimicrob Agents 2020;56:106188. [PMID: 33045352 DOI: 10.1016/j.ijantimicag.2020.106188] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kaur J, Cao X, Abutaleb NS, Elkashif A, Graboski AL, Krabill AD, AbdelKhalek AH, An W, Bhardwaj A, Seleem MN, Flaherty DP. Optimization of Acetazolamide-Based Scaffold as Potent Inhibitors of Vancomycin-Resistant Enterococcus. J Med Chem 2020;63:9540-62. [PMID: 32787141 DOI: 10.1021/acs.jmedchem.0c00734] [Cited by in Crossref: 14] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
14 Dubey KK, Indu, Sharma M. Reprogramming of antibiotics to combat antimicrobial resistance. Arch Pharm 2020;353:2000168. [DOI: 10.1002/ardp.202000168] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Shahin IG, Abutaleb NS, Alhashimi M, Kassab AE, Mohamed KO, Taher AT, Seleem MN, Mayhoub AS. Evaluation of N-phenyl-2-aminothiazoles for treatment of multi-drug resistant and intracellular Staphylococcus aureus infections. Eur J Med Chem 2020;202:112497. [PMID: 32707373 DOI: 10.1016/j.ejmech.2020.112497] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
16 Seong YJ, Alhashimi M, Mayhoub A, Mohammad H, Seleem MN. Repurposing Fenamic Acid Drugs To Combat Multidrug-Resistant Neisseria gonorrhoeae. Antimicrob Agents Chemother 2020;64:e02206-19. [PMID: 32393483 DOI: 10.1128/AAC.02206-19] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
17 Butler MS, Paterson DL. Antibiotics in the clinical pipeline in October 2019. J Antibiot (Tokyo) 2020;73:329-64. [PMID: 32152527 DOI: 10.1038/s41429-020-0291-8] [Cited by in Crossref: 63] [Cited by in F6Publishing: 96] [Article Influence: 31.5] [Reference Citation Analysis]
18 Vadlamani RA, Dhanabal A, Detwiler DA, Pal R, McCarthy J, Seleem MN, Garner AL. Nanosecond electric pulses rapidly enhance the inactivation of Gram-negative bacteria using Gram-positive antibiotics. Appl Microbiol Biotechnol 2020;104:2217-27. [PMID: 31965221 DOI: 10.1007/s00253-020-10365-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
19 Dayal N, Opoku-Temeng C, Mohammad H, Abutaleb NS, Hernandez D, Onyedibe KI, Wang M, Zeller M, Seleem MN, Sintim HO. Inhibitors of Intracellular Gram-Positive Bacterial Growth Synthesized via Povarov-Doebner Reactions. ACS Infect Dis 2019;5:1820-30. [PMID: 31512848 DOI: 10.1021/acsinfecdis.9b00022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
20 Abutaleb NS, Seleem MN. Antivirulence activity of auranofin against vancomycin-resistant enterococci: in vitro and in vivo studies. Int J Antimicrob Agents 2020;55:105828. [PMID: 31669742 DOI: 10.1016/j.ijantimicag.2019.10.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
21 Shao X, AbdelKhalek A, Abutaleb NS, Velagapudi UK, Yoganathan S, Seleem MN, Talele TT. Chemical Space Exploration around Thieno[3,2-d]pyrimidin-4(3H)-one Scaffold Led to a Novel Class of Highly Active Clostridium difficile Inhibitors. J Med Chem 2019;62:9772-91. [PMID: 31584822 DOI: 10.1021/acs.jmedchem.9b01198] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
22 Alhashimi M, Mayhoub A, Seleem MN. Repurposing salicylamide for combating multidrug-resistant Neisseria gonorrhoeae. Antimicrob Agents Chemother 2019:AAC. [PMID: 31570391 DOI: 10.1128/AAC.01225-19] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
23 Hammad A, Abutaleb NS, Elsebaei MM, Norvil AB, Alswah M, Ali AO, Abdel-Aleem JA, Alattar A, Bayoumi SA, Gowher H, Seleem MN, Mayhoub AS. From Phenylthiazoles to Phenylpyrazoles: Broadening the Antibacterial Spectrum toward Carbapenem-Resistant Bacteria. J Med Chem 2019;62:7998-8010. [PMID: 31369262 DOI: 10.1021/acs.jmedchem.9b00720] [Cited by in Crossref: 18] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
24 Mohammad H, Kyei-Baffour K, Abutaleb NS, Dai M, Seleem MN. An aryl isonitrile compound with an improved physicochemical profile that is effective in two mouse models of multidrug-resistant Staphylococcus aureus infection. J Glob Antimicrob Resist 2019;19:1-7. [PMID: 31051286 DOI: 10.1016/j.jgar.2019.04.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
25 Elsebaei MM, Mohammad H, Samir A, Abutaleb NS, Norvil AB, Michie AR, Moustafa MM, Samy H, Gowher H, Seleem MN, Mayhoub AS. Lipophilic efficient phenylthiazoles with potent undecaprenyl pyrophosphatase inhibitory activity. Eur J Med Chem 2019;175:49-62. [PMID: 31075608 DOI: 10.1016/j.ejmech.2019.04.063] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
26 Domalaon R, Okunnu O, Zhanel GG, Schweizer F. Synergistic combinations of anthelmintic salicylanilides oxyclozanide, rafoxanide, and closantel with colistin eradicates multidrug-resistant colistin-resistant Gram-negative bacilli. J Antibiot (Tokyo) 2019;72:605-16. [PMID: 31028351 DOI: 10.1038/s41429-019-0186-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
27 Davido B, Batista R, Dinh A, de Truchis P, Terveer EM, Roberts B, Kuijper EJ, Caballero S. Fifty shades of graft: How to improve the efficacy of faecal microbiota transplantation for decolonization of antibiotic-resistant bacteria. Int J Antimicrob Agents 2019;53:553-6. [PMID: 30880228 DOI: 10.1016/j.ijantimicag.2019.03.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
28 Kotb A, Abutaleb NS, Hagras M, Bayoumi A, Moustafa MM, Ghiaty A, Seleem M, Mayhoub AS. tert -Butylphenylthiazoles with an oxadiazole linker: a novel orally bioavailable class of antibiotics exhibiting antibiofilm activity. RSC Adv 2019;9:6770-8. [DOI: 10.1039/c8ra10525a] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
29 Hagras M, Abutaleb NS, Ali AO, Abdel-Aleem JA, Elsebaei MM, Seleem MN, Mayhoub AS. Naphthylthiazoles: Targeting Multidrug-Resistant and Intracellular Staphylococcus aureus with Biofilm Disruption Activity. ACS Infect Dis 2018;4:1679-91. [PMID: 30247876 DOI: 10.1021/acsinfecdis.8b00172] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
30 AbdelKhalek A, Abutaleb NS, Mohammad H, Seleem MN. Antibacterial and antivirulence activities of auranofin against Clostridium difficile. Int J Antimicrob Agents 2019;53:54-62. [PMID: 30273668 DOI: 10.1016/j.ijantimicag.2018.09.018] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
31 AbdelKhalek A, Abutaleb NS, Mohammad H, Seleem MN. Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE). PLoS One 2018;13:e0199710. [PMID: 29953486 DOI: 10.1371/journal.pone.0199710] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
32 AbdelKhalek A, Abutaleb NS, Elmagarmid KA, Seleem MN. Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci. Sci Rep 2018;8:8353. [PMID: 29844350 DOI: 10.1038/s41598-018-26674-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 9.8] [Reference Citation Analysis]